Skip to content

Comparison between Submandibular salivary gland removal vs preservation during surgery for early stages of oral squamous cell carcinoma

Comparison of Submandibular gland excision vs preservation during Supraomohyoid neck dissection for T1,T2,N0 Oral squamous cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030755
Enrollment
30
Registered
2021-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C01- Malignant neoplasm of base of tongue Health Condition 2: C021- Malignant neoplasm of border of tongue Health Condition 3: C020- Malignant neoplasm of dorsal surface of tongue Health Condition 4: C039- Malignant neoplasm of gum, unspecified Health Condition 5: C031- Malignant neoplasm of lower gum Health Condition 6: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx Health Condition 7: C029- Malignant neoplasm of tongue, unspecified Health Condi

Interventions

Intervention1: Preservation of Submandibular gland during supraomohoid neck dissection: During neck dissection after excision of the primary lesion for T1,T2,N0 oral squamous cell carcinoma, preservat

Sponsors

Kalinga Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with T1,T2,N0 oral squamous cell carcinoma and undergoing supraomohyoid neck neck dissection.

Exclusion criteria

Exclusion criteria: Patients with advanced stages of oral squamous cell carcinoma (OSCC). OSCC involving the floor of the mouth. OSCC with direct invasion of the submandibular gland. Inoperable patients.

Design outcomes

Secondary

MeasureTime frame
Incidence of early nodal failure. Incidence of xerostomiaTimepoint: 1 year

Primary

MeasureTime frame
Operative outcome of preservation of submandibular gland in terms of time taken for surgery, blood loss, lymphnode yield.Timepoint: Postop day-1. Intraop findings Postop day-7 Histopathology findings

Countries

India

Contacts

Public ContactDr Sabyasachi Parida

Kalinga Institute of Medical Sciences

sabyasachi.parida@kims.ac.in8895156986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026